Clinical trial
Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test at the Department of Pathology at the Grand Hôpital de Charleroi.
NCT07868640 is registered in ClinicalTrials.gov with Grand Hôpital de Charleroi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test at the Department of Pathology at the Grand Hôpital de Charleroi.
- Lead sponsor
- Grand Hôpital de Charleroi
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 15, 2026
- Completion date
- December 30, 2028
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer